Protein hormones and immunity

Brain, Behavior, and Immunity

Volumn 21, Issue 4, 2007, Pages 384-392

  Kelley, Keith W ^a,d   Weigent, Douglas A ^b   Kooijman, Ron ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d Department of Chemistry   (United States)

Author keywords

Growth hormone; Hormone resistance; IGF I; Immunity; Inflammation; Prolactin; Thyroid stimulating hormone

Indexed keywords

HORMONE; PROTEIN;

ARTICLE; BRAIN FUNCTION; CYTOKINE RELEASE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; LIGAND BINDING; NERVOUS SYSTEM; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL;

ANIMALS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; PROLACTIN; PSYCHONEUROIMMUNOLOGY; RECEPTORS, CYTOKINE;

EID: 34147140734     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.11.010     Document Type: Article

References (59)

1. Argetsinger L.S., and Carter-Su C. Mechanism of signaling by growth hormone receptor. Physiol. Rev. 76 (1996) 1089-1107
2. Arkins S., Rebeiz N., Biragyn A., Reese D.L., and Kelley K.W. Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 133 (1993) 2334-2343
3. Auernhammer C.J., and Melmed S. The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J. Clin. Invest. 108 (2001) 1735-1740
4. Berczi I. The immunology of prolactin. Semin. Reprod. Endocrinol. 10 (1992) 196-219
5. Berwaer M., Martial J.A., and Davis J.R.E. Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol. Endocrinol. 8 (1994) 635-642
6. Blecha F., Barry R.A., and Kelley K.W. Stress-induced alterations in delayed-type hypersensitivity to SRBC and contact sensitivity to DNFB in mice. Proc. Soc. Exp. Biol. Med. 169 (1982) 239-246
7. Blecha F., Kelley K.W., and Satterlee D.G. Adrenal involvement in the expression of delayed-type hypersensitivity to SRBC and contact sensitivity to DNFB in stressed mice. Proc. Soc. Exp. Biol. Med. 169 (1982) 247-252
8. Bouchard B., Ormandy C.J., Di Santo J.P., and Kelly P.A. Immune system development and funciton in prolactin receptor-deficient mice. J. Immunol. 163 (1999) 576-582
9. Carro E., Trejo J.L., Busiguina S., and Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of exercise against brain insults of different etiology and anatomy. J. Neurosci. 21 (2001) 5678-6684
10. Deijen J.B., and Arwert L.I. Impaired quality of life in hypopituitary adults with growth hormone deficiency: can somatotropin replacement therapy help?. Treat. Endocrinol. 5 (2006) 243-250
11. Dimitrov S., Lange T., Fehm H.L., and Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav. Immun. 18 (2004) 368-374
12. Dobashi H., Sato M., Tanake T., Tokuda M., and Ishida T. Growth hormone restores glucocorticoid-induced T cell suppression. FASEB J. 15 (2001) 1861-1863
13. Dorshkind K., and Horseman N.D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 21 (2000) 292-312
14. Dorshkind K., and Horseman N.D. Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23 (2001) 288-294
15. Dugan A.L., Thellin O., Buckley D.J., Buckley A.R., Ogle C.K., and Horseman N.D. Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology 143 (2002) 4147-4151
16. Dunham D.M., Arkins S., Edwards III C.K., Dantzer R., and Kelley K.W. Role of interferon-gamma in counteracting the suppressive effects of transforming growth factor-beta 2 and glucocorticoids on the production of tumor necrosis factor-alpha. J. Leukoc. Biol. 48 (1990) 473-481
17. Edwards III C.K., Ghiasuddin S.M., Yunger L.M., Lorence R.M., Arkins S., Dantzer R., and Kelley K.W. In vivo administration of recombinant growth hormone or interferon-γ activates macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with the generation of reactive oxygen intermediates. Infect. Immun. 60 (1992) 2514-2521
18. Edwards III C.K., Yunger L.M., Lorence R.M., Dantzer R., and Kelley K.W. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 88 (1991) 2274-2277
19. Farmer J.T., and Weigent D.A. Expression of insulin-like growth factor-2 receptors on EL4 cells overexpressing growth hormone. Brain Behav. Immun. 21 (2007) 79-85
20. French R.A., Zachary J.F., Dantzer R., Frawley L.S., Chizzonite R., Parnet P., and Kelley K.W. Dual expression of p80 type I and p68 type II interleukin-1 receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology 137 (1996) 4027-4036
21. Fu Y.K., Arkins S., Fuh G., Cunningham B.C., Wells J.A., Fong S., Cronin M.J., Dantzer R., and Kelley K.W. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J. Clin. Invest. 89 (1992) 451-457
22. Gala R.R. Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 198 (1991) 513-527
23. Gellersen B., Kempf R., Telgmann R., and DiMattia G.E. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol. Endocrinol. 8 (1994) 356-373
24. Gerlo S., Davis J.R.E., Mager D., and Kooijman R. Prolactin in man: a tale of two promoters. Bioessays 28 (2006) 1051-1055
25. Gerlo S., Verdood P., Hooghe-Peters E.L., and Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J. Neuroimmunol. 162 (2005) 190-193
26. Hansson A., Hehenberger K., and Thoren M. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I). Cell Biochem. Funct. 14 (1996) 121-129
27. Heijnen C.J. Receptor regulation in neuro-endocrine-immune communication: current knowledge and future perspectives. Brain Behav. Immun. 21 1 (2007) 1-8
28. Hinton P.S., Peterson C.A., Lo H.C., Yang H., McCarthy D., and Ney D.M. Insulin-like growth factor-I enhances immune response in dexamethasone-treated or surgically stressed rats maintained with total parenteral nutrition. J. Paranter. Enteral. Nutr. 19 (1995) 444-452
29. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., and Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16 (1997) 6926-6935
30. Hotamisligil G.S. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 (2003) S53-S55
31. Huang H., Regan K.M., Lou Z., Chen J., and Tindall D.J. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314 (2006) 294-297
32. 3 pituitary adenoma implants can reverse thymic aging. Proc. Natl. Acad. Sci. USA 83 (1986) 5663-5667
33. Kelley K.W. Growth hormone, lymphocytes and macrophages. Biochem. Pharmacol. 38 (1989) 705-713
34. Kelley K.W. From hormones to immunity: the physiology of immunology. Brain Behav. Immun. 18 (2004) 95-113
35. Kelley K.W., Arkins S., and Li Y.M. Growth hormone, prolactin, and insulin-like growth factors: new jobs for old players. Brain Behav. Immun. 6 (1992) 317-326
36. Kelley K.W., and Dantzer R. Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation. In: Plotnikoff N., Murgo A., Faith R., and Wybran J. (Eds). Stress and Immunity (1991), CRC Press, Boca Raton, Florida 433-452
37. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 120 (2005) 449-460
38. Kooijman R., Hooghe-Peters E.L., and Hooghe R. Prolactin, growth hormone and insulin-like growth factor-1 in the immune system. Adv. Immunol. 63 (1996) 377-453
39. Lang C.H., Hong-Brown L., and Frost R.A. Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance. Pediatr. Nephrol. 20 (2005) 306-312
40. Matera L., Cesano A., Bellone G., and Oberholtzer E. Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes. Brain Behav. Immun. 6 (1992) 409-417
41. Matera L., Muccioli G., Cesano A., Bellussi G., and Genazzani E. Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A. Brain Behav. Immun. 2 (1988) 1-10
42. McCusker R.H., Strle K., Broussard S.R., Dantzer R., Bluthé R.M., and Kelley K.W. Crosstalk between insulin-like growth gactors and proinflammatory cytokines. In: Ader R. (Ed). Psychoneuroimmunology. Fourth Ed. (2006), Elsevier, Amsterdam, The Netherlands 171-192
43. Murphy W.J., Durum S.K., Anver M.R., and Longo D.L. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J. Immunol. 148 (1992) 3799-3805
44. Murphy W.J., Durum S.K., and Longo D.L. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178 (1993) 231-236
45. Nagafuchi H., Suzuki N., Kaneko A., Asai T., and Sakane T. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 26 (1999) 1890-1900
46. Pace T., Hu F., and Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 21 1 (2007) 9-19
47. Peeva E., Venkatesh J., Michael D., and Diamond B. Prolactin as a modulator of B cell function: implications for SLE. Biomed. Pharmacother. 58 (2004) 310-319
48. Pierpaoli W., Baroni C., Fabris N., and Sorkin E. Hormones and immunological capacity. II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin. J. Immunol. 16 (1969) 217-230
49. Russell D.H., Kibler R., Matrisian L., Larson D.F., Poulos B., and Magun B.E. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J. Immunol. 134 (1985) 3027-3031
50. Sarna S., Sipila I., Ronnholm K., Koistinen R., and Holmberg C. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation. J. Clin. Endocrinol. Metab. 81 (1996) 1476-1482
51. Savino W., Smaniotto S., Binart N., Postel-Vinay M.C., and Dardenne M. In vivo effects of growth hormone on thymic cells. Ann. N. Y. Acad. Sci. 992 (2003) 179-185
52. Shen W.H., Yin Y., Broussard S.R., McCusker R.H., Freund G.G., Dantzer R., and Kelley K.W. Tumor necrosis factor α inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J. Biol. Chem. 279 (2004) 7438-7446
53. Sonntag W.E., Carter C.S., Ikeno Y., Ekenstedt K., Carlson C.S., Loeser R.F., Chakrabarty S., Lee S., Bennett C., Ingram R., Moore T., and Ramsey M. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146 (2005) 2920-2932
54. Strle K., Broussard S.R., McCusker R.H., Shen W.H., LeCleir J.M., Johnson R.W., Freund G.G., Dantzer R., and Kelley K.W. C-jun N-terminal kinase mediates TNFα suppression of differentiation in myoblasts. Endocrinology 147 (2006) 4363-4373
55. Sun L.Y., Evans M.S., Hsieh J., Panici J., and Barke A. Increase neurogenesis in dentate gyrus of long-lived Ames dwarf mice. Endocrinology 146 (2005) 1138-1144
56. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., and Maier S.F. Glia as the bad guys: implications for improving clinical pain control and the clinical utility of opioids. Brain Behav. Immun. 21 2 (2007) 137-152
57. Weigent D.A. Immunoregulatory properties of growth hormone and prolactin. J. Pharmacol. Therapeut 69 (1996) 237-257
58. Weigent, D.A., Blalock, J.E., 2007. Bidirectional communication between the brain and the immune system. Pandi-Perumal,S.R., Cardinali, D.P., Chrousos,G.P. (Eds.), Neuroimmunology of Sleep. Springer, NY (in press).
59. Zhu T., Starling-Emerald B., Zhang X., Lee K.-O., Gluckman P.D., Mertani H.C., and Lobie P.D. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res. 65 (2005) 317-324